VIGORITA, Maria
 Distribuzione geografica
Continente #
NA - Nord America 1.556
EU - Europa 1.315
AS - Asia 284
OC - Oceania 1
SA - Sud America 1
Totale 3.157
Nazione #
US - Stati Uniti d'America 1.554
IE - Irlanda 400
SE - Svezia 383
CN - Cina 217
UA - Ucraina 192
DE - Germania 121
FI - Finlandia 64
GB - Regno Unito 53
IT - Italia 53
SG - Singapore 33
IN - India 22
FR - Francia 12
IR - Iran 12
RU - Federazione Russa 12
BE - Belgio 8
CZ - Repubblica Ceca 6
GR - Grecia 5
NO - Norvegia 3
CA - Canada 2
AT - Austria 1
AU - Australia 1
CH - Svizzera 1
CL - Cile 1
PT - Portogallo 1
Totale 3.157
Città #
Dublin 399
Jacksonville 352
Chandler 275
Nyköping 265
Dearborn 188
Beijing 79
Cambridge 61
Medford 61
Princeton 61
Ann Arbor 45
Ashburn 44
Boardman 40
Des Moines 37
Jinan 26
Lancaster 21
San Mateo 21
Singapore 15
Haikou 12
New York 12
Woodbridge 12
Ardabil 10
Shenyang 10
Wilmington 10
Nanchang 9
Tianjin 9
Brussels 8
Nanjing 8
Bremen 6
Guangzhou 6
Hebei 6
Seattle 6
Brno 5
Changsha 5
Fuzhou 5
Hangzhou 5
Monmouth Junction 5
Ningbo 5
Pune 5
Taiyuan 5
Taizhou 5
Augusta 4
Houston 4
Los Angeles 4
Milan 4
Norwalk 4
Turin 4
Washington 4
Zhengzhou 4
Hefei 3
Helsinki 3
Hyderabad 3
Mountain View 3
Nocera Terinese 3
Pietra Ligure 3
Riva 3
Saint Petersburg 3
Auburn Hills 2
Breganze 2
Clearwater 2
Jiaxing 2
Kunming 2
Leawood 2
Mumbai 2
Redmond 2
Santa Clara 2
Aarau 1
Aci Catena 1
Bangalore 1
Brescia 1
Buffalo 1
Büdelsdorf 1
Chiavari 1
Chongqing 1
Edinburgh 1
Evanston 1
Jinhua 1
Kemerovo 1
La Canada Flintridge 1
Lanzhou 1
Lisbon 1
Livorno 1
Messina 1
Modesto 1
Nembro 1
New Delhi 1
Perth 1
Pisa 1
Redwood City 1
Regensburg 1
Rende 1
Saint-Georges 1
San Giovanni La Punta 1
Sant'elpidio A Mare 1
Siena 1
Spilimbergo 1
Tappahannock 1
Tooting 1
Torre Del Greco 1
Vienna 1
Warren 1
Totale 2.268
Nome #
4-Carbossiamido-9-fluorenoni: proprietà anti-HSV-2 e immunostimolanti 78
2/4-Substituted-9-fluorenones and their O-glucosides as potential immunomodulators and anti-herpes simplex virus-2 agents.Part 5 76
Modeling and biological evaluation of 3.3 '-(1,2- ethanediyl)bis[2-(4-methoxyphenyl)-thiazolidin-4-one], a new synthetic cyclooxygenase-2 inhibitor 74
FLUOROCONTAINING D-CYCLOSERINES - SYNTHESIS AND INVITRO EVALUATION OF ANTIMICROBIAL AND ANTIVIRAL ACTIVITIES 73
5-Arylidene-2-imino-4-thiazolidinones: Design and synthesis of novel anti-inflammatory agents 70
Evaluation of in vitro aldose reductase inhibitory activity of 5-arylidene-2,4-thiazolidinediones. 68
Nickel(II) 2,6-diacetylpyridine bis(isonicotinoylhydrazonate) and bis(benzoylhydrazonate) complexes: Structure and antimycobacterial evaluation. Part XI 68
5-Ariliden-2,4-tiazolidindioni potenziali antidiabetici inibitori della protein tirosina fosfatasi 1B 65
Design and synthesis of 5-arylidene-2-imino-4-thiazolidinones Celecoxib analogues as antiinflammatory and anticancer agents 64
5-Arylidene-2,4-thiazolidinediones. Synthesis and in vitro activity as ALR2 inhibitors 64
5-Arylidene-2,4-thiazolidinediones as inhibitors of protein tyrosine phosphatases 64
Antimycobacterial in vitro activity of cobalt(II) isonicotinoylhydrazone complexes. Part 10 63
2-Phenylimino-5-arylidene-4-thiazolidinones. Synthesis and pharmacological evaluation on IL-1induced alteration in cartilage metabolism. 63
5-Ariliden-2,4-tiazolidindioni inibitori dell'aldoso reduttasi e potenziali agenti antiiperglicemizzanti 61
Synthesis and antiinflammatory, analgesic activity of 3,3’-(1,2-ethanediyl)-bis[2-aryl-4-thiazolidinone] chiral compounds. Part 10. 61
9-fluorenon-4-carboxamides: synthesis, conformational analysis, anti-HSV-2, and immunomodulatory evaluation. Note II 59
Relazioni Struttura/Attività e molecular modelling di 5-ariliden-2,4-tiazolidindioni inibitori dell'aldoso reduttasi 58
5-Arilmetilen- e 5-arilmetil-2,4-tiazolidindioni inibitori dell'aldoso reduttasi 58
Synthesis and in vitro evaluation of 5-arylidene-3-hydroxyalkyl-2-phenylimino-4-thiazolidinones with antidegenerative activity on human chondrocyte cultures 58
2 '-[1-(4-Fluorophenyl)ethyl]isonicotino-kappa N-hydrazide- cyanoborane 58
Tilorone analogues with IFN-inducing and anti-HSV-2 activity 56
Progettazione e sintesi di derivati fluorenici intercalanti ad attività IFN-inducente ed anti-HSV-2 55
Configurational assignments of the diastereomers of 3,3 '-(1,2- ethanediyl)bis[2-(3-fluorophenyl)-5-methyl-4-thiazolidinone] derivative with four stereogenic centers 55
Synthesis and aldose reductase inhibitory activity of 5-arylidene-2,4-thiazolidinediones 55
Facile biocatalytic access to 9-fluorenylmethyl polyglycosides: evaluation of antiviral activity on immunocompetent cells 55
Progettazione, sintesi e attivita' farmacologica di nuovi derivati fluorenonici intercalanti 54
INH-related hydrazides and cyanoboranes with antimycobacterial in vitro activity 54
Bistiazolidinoni chirali: SARs molecular modeling, inibizione COX-I/COX-2 54
5-Arylidene-2,4-thiazolidinediones as protein tyrosine phosphatases inhibitors 53
In vitro antimycobacterial activities of 2 '-monosubstituted isonicotinohydrazides and their cyanoborane adducts 53
Chiral 3,3 '-(1,2-ethanediyl)-bis[2-(3,4-dimethoxyphenyl)-4- thiazolidinones] with anti-inflammatory activity. Part 11: Evaluation of COX-2 selectivity and modelling 53
Biocatalysed synthesis of beta-O-glucosides from 9-fluorenon-2-carbohydroxyesters. Part 3: IFN-inducing and anti-HSV-2 properties 52
Design and synthesis of DNA-intercalating 9-fluoren-beta-O-glycosides as potential IFN-inducers, and antiviral and cytostatic agents 51
Structure-activity relationships and molecular modelling of 5-arylidene-2,4-thiazolidinediones active as aldose reductase inhibitors 49
Fluoren b-O-glucosides: biosynthesis and DNA-intercalating activity evaluation 49
Lipophilic analogs of isoniazid with antiproliferative in vitro activity - VIII 49
Nuclear magnetic resonance of psychotherapeutic agents. IV. Conformational analysis of 2,3-dihydro.1H-1,4-benzodiazepines 49
In vitro antiproliferative activity against human colon cancer cell lines of representative 4-thiazolidinones. Part I 49
In vitro Antimycobacterial Activity of Isoniazid-related Metalchelates 48
Synthesis and in vitro antimicrobial and antitumoral screening of novel lipophilic isoniazid analogues. VI. 48
Evaluation of COX-2 selectivity and molecular modeling of novel 3,3'-(1,2-ethanediyl)bis-[2-(methoxyphenyl)-thiazolidin-4-ones] with antiinflammatory activity 47
Nuclear magnetic resonance spectra of psychotherapeutic agents. V. Conformational analysis of 1,3,4,5-tetrahydro-2H-1,5-benzodiazepin-2-ones 47
Inibitori COX-2 selettivi a struttura tiazolidinonica. Valutazione dell'attività citotossica su linee cellulari di carcinoma del colon umano 46
In vitro advanced antimycobacterial screening of cobalt(II) and copper(II) complexes of fluorinated isonicotinoylhydrazones 46
Cyanoborane adducts of isonicotinohydrazides. Synthesis and evaluation of antineoplastic activity. 46
Risonanza magnetica nucleare di 1,4-benzodiazepine. Accoppiamento attraverso lo spazio di 2,3-diidro-1H-1,4-benzodiazepine 1-sostituite 45
Synthesis and in vivo/ex vivo antiinflammatory evaluation of 5-arylidene-2-imino-4-thiazolidinones as potential celecoxib analogues 44
Sintesi, attività in vitro e SARs di 2,4-tiazolidindioni inibitori dell'aldoso reduttasi 43
Isoniazid-related copper(II) and nickel(II) complexes with antimycobacterial in vitro activity. Part 9 43
Isonicotinoilidrazoni: reattività con diazometano ed attività antimicobatterica ed anti-HIV 41
In vitro advanced antimycobacterial screening of isoniazid-related hydrazones, hydrazides and cyanoboranes: Part 14 40
Sintesi, attività e molecular modelling di 5-ariliden-2,4-tiazolidindioni inibitori della PTP1B. 40
In Vitro Aldose Reductase Inhibitory Activity of 5-Benzyl-2,4-thiazolidinediones 40
Halogenated isoniazid derivatives .6. Evaluation of anti-HSV-1 and anti-HIV-1 in vitro activities of fluorinated analogues 39
Tetraplex DNA specific ligand based on the fluorenone-carboxamide scaffold. 38
Nuclear magnetic resonance of 1,4-benzodiazepines. II. Stereochemistry of 1,3-dihydro-2H-1,4-benzodiazepin-2-ones by lanthanide shift reagents 36
Isonicotinoilidrazoni fluorurati: reattività ed attività antimicobatterica ed anti-HIV 33
Metal(II) complexes with isoniazid analogues: synthesis and pharmacological activity 32
Nuclear magnetic resonance spectra of psychotherapeutic agents. III. Stereochemistry of 1-methyl5-phenyl-2,3,4,5-tetrahydro-1H-1,5-benzodiazepine-2,4-diones 30
Reattività di isonicotinoilidrazoni con diazometano 29
Metalchelati di aroilidrazoni. Sintesi e valutazione dell'attività antitubercolare 28
Totale 3.177
Categoria #
all - tutte 12.255
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.255


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020575 0 50 1 50 54 123 120 67 10 25 74 1
2020/2021393 53 5 73 13 13 50 5 49 1 53 67 11
2021/2022413 6 94 3 10 22 0 27 14 6 27 70 134
2022/20231.161 94 130 57 100 76 118 27 57 476 9 17 0
2023/2024204 16 34 32 13 24 42 1 13 0 3 0 26
2024/202519 13 6 0 0 0 0 0 0 0 0 0 0
Totale 3.177